Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

Clinical Evidence

 

 

A review discussing the use of polyethylene glycol microspheres in the treatment of hepatocellular carcinomahttps://www.terumo-europe.com/en-emea/clinicaldata/a-review-discussing-the-use-of-polyethylene-glycol-microspheres-in-the-treatment-of-hepatocellular-carcinomaA review discussing the use of polyethylene glycol microspheres in the treatment of hepatocellular carcinoma18/12/2018 23:00:00<p>​Giammaria Fiorentini, Donatella Sarti, Riccardo Carandina, Luca Mulazzani, Cinzia Mincarelli, Roberto Candelari, Renato Argirò, Caterina Fiorentini & Camillo Aliberti<br></p>
Chemoembolization in Conjunction with Bevacizumab: Preliminary Resultshttps://www.terumo-europe.com/en-emea/clinicaldata/chemoembolization-in-conjunction-with-bevacizumab-preliminary-resultsChemoembolization in Conjunction with Bevacizumab: Preliminary Results18/12/2018 23:00:00<p>Giammaria Fiorentini, MD, Donatella Sarti, PhD, Camillo Aliberti, MD, Riccardo Carandina, MD, Luca Mulazzani, MD, Alessandro Felicioli, MD, Stefano Guadagni, MD<br></p>
Navicross in The Subintimal Recanalization of Fempop CTOs:https://www.terumo-europe.com/en-emea/clinical-program/Pages/Navicross-in-The-Subintimal-Recanalization-of-Fempop-CTOs.aspxNavicross in The Subintimal Recanalization of Fempop CTOs:04/10/2018 22:00:00
Glidewire Advantage & NaviCross Case Reportshttps://www.terumo-europe.com/en-emea/clinical-program/Pages/Glidewire-Advantage-NaviCross-Case-Reports.aspxGlidewire Advantage & NaviCross Case Reports04/10/2018 22:00:00
Ultimaster Clinical Programhttps://www.terumo-europe.com/en-emea/clinicaldata/the-comprehensive-clinical-programmeUltimaster Clinical ProgramGlobal06/09/2018 22:00:00